SEC 13F Intelligence

Aquilo Capital Management, LLC / DTIL

Aquilo Capital Management, LLC’s Precision Biosciences Inc Position

Does Aquilo Capital Management, LLC own Precision Biosciences Inc (DTIL)? Not currently — the last reported position was 726.1K shares worth $3M in Q1 2025; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$3M
Q1 2025
Shares
726.1K
% of Portfolio
+6.21%
Quarters Held
5
position exited

Position History DTIL

Reported value by quarter
Q1 ’24: $5MQ1 ’24Q2 ’24: $4MQ2 ’24Q3 ’24: $3MQ3 ’24Q4 ’24: $2MQ4 ’24Q1 ’25: $3MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025726.1K$3M+6.21%
Q4 2024536.4K$2M+3.08%
Q3 2024381.8K$3M+2.59%
Q2 2024381.8K$4M+3.58%
Q1 2024385.4K$5M+3.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aquilo Capital Management, LLC’s full portfolio or all institutional holders of DTIL.